Trials / Completed
CompletedNCT02354378
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 4 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in children has not been studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | |
| OTHER | Memory Test |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-02-03
- Last updated
- 2019-02-28
- Results posted
- 2019-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02354378. Inclusion in this directory is not an endorsement.